Quantbot Technologies LP Buys 28,872 Shares of Maximus, Inc. (NYSE:MMS)

Quantbot Technologies LP raised its stake in shares of Maximus, Inc. (NYSE:MMS) by 228.6% during the 4th quarter, according to its most recent filing with the SEC. The firm owned 41,500 shares of the health services provider’s stock after acquiring an additional 28,872 shares during the period. Quantbot Technologies LP’s holdings in Maximus were worth $3,098,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also bought and sold shares of the company. UMB Bank n.a. lifted its stake in Maximus by 79.8% during the 4th quarter. UMB Bank n.a. now owns 356 shares of the health services provider’s stock valued at $27,000 after acquiring an additional 158 shares during the period. Eastern Bank purchased a new stake in shares of Maximus during the 4th quarter valued at about $29,000. V Square Quantitative Management LLC increased its position in shares of Maximus by 65.9% during the 4th quarter. V Square Quantitative Management LLC now owns 453 shares of the health services provider’s stock valued at $34,000 after purchasing an additional 180 shares during the last quarter. R Squared Ltd purchased a new stake in shares of Maximus during the 4th quarter valued at about $54,000. Finally, IFP Advisors Inc increased its position in shares of Maximus by 62.4% during the 4th quarter. IFP Advisors Inc now owns 786 shares of the health services provider’s stock valued at $59,000 after purchasing an additional 302 shares during the last quarter. Institutional investors own 97.21% of the company’s stock.

Wall Street Analyst Weigh In

Several equities research analysts have recently commented on MMS shares. Raymond James raised shares of Maximus from a “market perform” rating to an “outperform” rating and set a $90.00 price target for the company in a research report on Thursday, January 2nd. StockNews.com lowered shares of Maximus from a “buy” rating to a “hold” rating in a research report on Friday, February 14th.

Maximus Price Performance

NYSE MMS opened at $67.12 on Friday. Maximus, Inc. has a 12 month low of $63.77 and a 12 month high of $93.97. The stock has a market cap of $3.80 billion, a price-to-earnings ratio of 14.43 and a beta of 0.71. The company’s 50 day moving average is $71.07 and its two-hundred day moving average is $78.55. The company has a current ratio of 1.72, a quick ratio of 1.72 and a debt-to-equity ratio of 0.82.

Maximus (NYSE:MMS) last released its earnings results on Thursday, February 6th. The health services provider reported $1.61 EPS for the quarter, topping analysts’ consensus estimates of $1.39 by $0.22. Maximus had a net margin of 5.28% and a return on equity of 21.95%. As a group, research analysts anticipate that Maximus, Inc. will post 6.15 earnings per share for the current year.

Maximus Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Friday, February 28th. Shareholders of record on Saturday, February 15th were paid a dividend of $0.30 per share. This represents a $1.20 dividend on an annualized basis and a yield of 1.79%. The ex-dividend date was Friday, February 14th. Maximus’s payout ratio is 25.81%.

Insiders Place Their Bets

In other news, Director Jan Madsen sold 2,439 shares of Maximus stock in a transaction that occurred on Tuesday, March 18th. The shares were sold at an average price of $67.71, for a total transaction of $165,144.69. Following the sale, the director now owns 18,097 shares in the company, valued at $1,225,347.87. This trade represents a 11.88 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Also, insider Ilene R. Baylinson sold 14,500 shares of Maximus stock in a transaction that occurred on Wednesday, February 19th. The shares were sold at an average price of $68.14, for a total transaction of $988,030.00. Following the sale, the insider now owns 2,512 shares in the company, valued at approximately $171,167.68. The trade was a 85.23 % decrease in their position. The disclosure for this sale can be found here. 1.60% of the stock is owned by company insiders.

Maximus Profile

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.